Laura Sutcliffe
Stock Analyst at Citigroup
(0.44)
# 4,215
Out of 5,124 analysts
9
Total ratings
33.33%
Success rate
-17.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | Initiates: Buy | $22 | $7.46 | +194.91% | 3 | Sep 18, 2025 | |
| RMD ResMed | Initiates: Buy | $330 | $249.19 | +32.43% | 3 | Sep 18, 2025 | |
| ARGX argenx SE | Initiates: Buy | $390 | $803.74 | -51.48% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $32.49 | - | 2 | Dec 20, 2019 |
Telix Pharmaceuticals
Sep 18, 2025
Initiates: Buy
Price Target: $22
Current: $7.46
Upside: +194.91%
ResMed
Sep 18, 2025
Initiates: Buy
Price Target: $330
Current: $249.19
Upside: +32.43%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $803.74
Upside: -51.48%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $32.49
Upside: -